Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

High-throughput screen for protein inhibitors of CRISPR-Cas systems: discovery and mechanistic categorization

FY 2016-17

Summary
CRISPR-Cas, a recently discovered gene-editing technology, is a game-changer. Not only is it more precise than previously developed gene-editing tools, but it is also cheaper, faster, and easier to use. These qualities have made CRISPR-Cas extremely attractive to researchers around the world and across a wide range of specialties. As a result, this gene-editing technology has been quickly adopted for use in biological, agricultural, veterinary, and medical research to create, for example, hardier crops and new cancer treatments. The lab where I will be conducting my research was the first in the world to discover anti-CRISPR proteins, which stop CRISPR-Cas from functioning. They were also the first to figure out how some anti-CRISPR proteins perform this important task. I will be continuing this work by asking key questions, such as: "What do anti-CRISPR proteins look like?", "Are they common and widespread?", "Do anti-CRISPR proteins carry out their work in different ways?", "Is stopping CRISPR-Cas from functioning their only job?", and "Can I design a computer program that will quickly and accurately categorize new anti-CRISPR proteins based on their predicted functions or structures?" In the laboratory, I will perform a high-throughput screen to look for binding partners (potential anti-CRISPR proteins) to the Cas proteins. In the office, I will write a computer program to interpret the laboratory results and to use information from other research groups to categorize and summarize our current knowledge of all known anti-CRISPR proteins. This work should provide us with a better understanding of how anti-CRISPR proteins work to stop CRISPR-Cas from functioning and anything else they might be doing. The results of my study may also lead to the use of anti-CRISPR proteins in combination with CRISPR-Cas as tools for biomedical research.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
362053
Name
Trost Chantel N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Not applicable / Specified
Prcname2
Fellowships - Post-PhD
Projecttitle
High-throughput screen for protein inhibitors of CRISPR-Cas systems: discovery and mechanistic categorization
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Anti-Crispr Proteins; Bacterial Two-Hybrid; Bioinformatics; Crispr-Cas; Genomic Dna Libraries; High-Throughput Functional Screen; Mechanisms Of Inhibition And Modulation; Protein-Protein Interactions; Type I-F
Abstract
CRISPR-Cas, a recently discovered gene-editing technology, is a game-changer. Not only is it more precise than previously developed gene-editing tools, but it is also cheaper, faster, and easier to use. These qualities have made CRISPR-Cas extremely attractive to researchers around the world and across a wide range of specialties. As a result, this gene-editing technology has been quickly adopted for use in biological, agricultural, veterinary, and medical research to create, for example, hardier crops and new cancer treatments. The lab where I will be conducting my research was the first in the world to discover anti-CRISPR proteins, which stop CRISPR-Cas from functioning. They were also the first to figure out how some anti-CRISPR proteins perform this important task. I will be continuing this work by asking key questions, such as: "What do anti-CRISPR proteins look like?", "Are they common and widespread?", "Do anti-CRISPR proteins carry out their work in different ways?", "Is stopping CRISPR-Cas from functioning their only job?", and "Can I design a computer program that will quickly and accurately categorize new anti-CRISPR proteins based on their predicted functions or structures?" In the laboratory, I will perform a high-throughput screen to look for binding partners (potential anti-CRISPR proteins) to the Cas proteins. In the office, I will write a computer program to interpret the laboratory results and to use information from other research groups to categorize and summarize our current knowledge of all known anti-CRISPR proteins. This work should provide us with a better understanding of how anti-CRISPR proteins work to stop CRISPR-Cas from functioning and anything else they might be doing. The results of my study may also lead to the use of anti-CRISPR proteins in combination with CRISPR-Cas as tools for biomedical research.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Trost, Chantel N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2016-17) | Canada Spends